HEMLIBRA 150 mg/mL, solution injectable

ReimbursedATC B02BX06

Last synced from Base de données publique des médicaments — BDPM (France) on June 3, 2026

Identification

ManufacturerROCHE REGISTRATION (ALLEMAGNE)

CountryFR (France)

ATC codeB02BX06

Dispensing—

ReimbursedYes

SourceBase de données publique des médicaments — BDPM (France)

Last synced6/3/2026

Packs · 4

cip13
3400930141427
1 flacon en verre de 0,4 ml
EUR 2.57
cip13
3400930141434
1 flacon en verre de 0,7 ml
EUR 4.39
cip13
3400930141441
1 flacon en verre de 1 ml
EUR 6.22
cip13
3400930272282
1 flacon(s) en verre de 2 ml
EUR 12.31

Annotations

No annotations yet.

Raw payload (JSON)

{
  "cis": "61529993",
  "date_amm": "2018-02-23",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/18/1271",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

Related drugs

Other records sharing ATC code B02BX06.

Access this data programmatically

Query HEMLIBRA 150 mg/mL, solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs